Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Faisal Aziz

Showing results (281-290 of 299) with videos related to

Pageof 30
Sort By:
Journal of Vascular Surgery. Venous and Lymphatic Disorders|May 13, 2022
Extended anticoagulation for venous thromboembolism: A survey of the American Venous Forum and the European Venous ForumMaxim E Shaydakov, Windsor Ting, Mikel Sadek, et al.
Diabetes, Obesity & Metabolism|October 10, 2019
Hypoglycaemia leads to a delayed increase in platelet and coagulation activation markers in people with type 2 diabetes treated with metformin only: Results from a stepwise hypoglycaemic clamp studyFelix Aberer, Peter N Pferschy, Norbert J Tripolt, et al.
Diabetes, Obesity & Metabolism|January 13, 2026
Impact of intermittent fasting on self-regulatory behaviour and sleep in participants with insulin-treated type 2 diabetes: A secondary analysis of the INTERFAST-2 randomised controlled trialAnna Ramirez-Obermayer, Norbert J Tripolt, Peter N Pferschy, et al.
Diabetes, Obesity & Metabolism|September 4, 2022
Severe acute respiratory syndrome coronavirus 2 spike antibody level decline is more pronounced after the second vaccination, but response to the third vaccination is similar in people with type 1 and type 2 diabetes compared with healthy controls: The prospective COVAC-DM cohort studyCaren Sourij, Faisal Aziz, Harald Kojzar, et al.
Diabetes Care|December 1, 2021
Impact of COVID-19 Vaccination on Glycemia in Individuals With Type 1 and Type 2 Diabetes: Substudy of the COVAC-DM StudyFelix Aberer, Othmar Moser, Faisal Aziz, et al.
Annals of Vascular Surgery|July 26, 2023
Fourth-Year Medical Students' Perceptions of Vascular Surgery: Can We Improve the Pipeline?Tyler Arismendi, Nicholas Schaper, Alec Falkenhain, et al.
Viruses|January 21, 2023
Only Subclinical Alterations in the Haemostatic System of People with Diabetes after COVID-19 VaccinationMargret Paar, Faisal Aziz, Caren Sourij, et al.
Clinical Research in Cardiology : Official Journal of the German Cardiac Society|September 19, 2024
Impact of empagliflozin on cardiac structure and function assessed by echocardiography after myocardial infarction: a post-hoc sub-analysis of the emmy trialNora Schwegel, Christoph Strohhofer, Ewald Kolesnik, et al.
Diabetes, Obesity & Metabolism|November 17, 2020
COVID-19 fatality prediction in people with diabetes and prediabetes using a simple score upon hospital admissionHarald Sourij, Faisal Aziz, Alexander Bräuer, et al.
NEJM Evidence|September 1, 2024
Ertugliflozin to Reduce Arrhythmic Burden in Patients with ICDs/CRT-DsMartin Benedikt, Abderrahim Oulhaj, Ursula Rohrer, et al.
Pageof 30

Showing results (281-290 of 299) with videos related to

Sort By:
Pageof 30
Journal of Vascular Surgery. Venous and Lymphatic Disorders|May 13, 2022
Extended anticoagulation for venous thromboembolism: A survey of the American Venous Forum and the European Venous ForumMaxim E Shaydakov, Windsor Ting, Mikel Sadek, et al.
Diabetes, Obesity & Metabolism|October 10, 2019
Hypoglycaemia leads to a delayed increase in platelet and coagulation activation markers in people with type 2 diabetes treated with metformin only: Results from a stepwise hypoglycaemic clamp studyFelix Aberer, Peter N Pferschy, Norbert J Tripolt, et al.
Diabetes, Obesity & Metabolism|January 13, 2026
Impact of intermittent fasting on self-regulatory behaviour and sleep in participants with insulin-treated type 2 diabetes: A secondary analysis of the INTERFAST-2 randomised controlled trialAnna Ramirez-Obermayer, Norbert J Tripolt, Peter N Pferschy, et al.
Diabetes, Obesity & Metabolism|September 4, 2022
Severe acute respiratory syndrome coronavirus 2 spike antibody level decline is more pronounced after the second vaccination, but response to the third vaccination is similar in people with type 1 and type 2 diabetes compared with healthy controls: The prospective COVAC-DM cohort studyCaren Sourij, Faisal Aziz, Harald Kojzar, et al.
Diabetes Care|December 1, 2021
Impact of COVID-19 Vaccination on Glycemia in Individuals With Type 1 and Type 2 Diabetes: Substudy of the COVAC-DM StudyFelix Aberer, Othmar Moser, Faisal Aziz, et al.
Annals of Vascular Surgery|July 26, 2023
Fourth-Year Medical Students' Perceptions of Vascular Surgery: Can We Improve the Pipeline?Tyler Arismendi, Nicholas Schaper, Alec Falkenhain, et al.
Viruses|January 21, 2023
Only Subclinical Alterations in the Haemostatic System of People with Diabetes after COVID-19 VaccinationMargret Paar, Faisal Aziz, Caren Sourij, et al.
Clinical Research in Cardiology : Official Journal of the German Cardiac Society|September 19, 2024
Impact of empagliflozin on cardiac structure and function assessed by echocardiography after myocardial infarction: a post-hoc sub-analysis of the emmy trialNora Schwegel, Christoph Strohhofer, Ewald Kolesnik, et al.
Diabetes, Obesity & Metabolism|November 17, 2020
COVID-19 fatality prediction in people with diabetes and prediabetes using a simple score upon hospital admissionHarald Sourij, Faisal Aziz, Alexander Bräuer, et al.
NEJM Evidence|September 1, 2024
Ertugliflozin to Reduce Arrhythmic Burden in Patients with ICDs/CRT-DsMartin Benedikt, Abderrahim Oulhaj, Ursula Rohrer, et al.
Pageof 30